202 related articles for article (PubMed ID: 35878014)
1. Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Lian BS; Lee HY
Expert Opin Drug Saf; 2022 Aug; 21(8):1039-1046. PubMed ID: 35878014
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
[TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
5. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
6. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
Prendiville JS; Hebert AA; Greenwald MJ; Esterly NB
J Pediatr; 1989 Dec; 115(6):881-7. PubMed ID: 2585222
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Ueta M
Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
[No Abstract] [Full Text] [Related]
8. Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.
Çekiç Ş; Canıtez Y; Sapan N
Turk Pediatri Ars; 2016 Sep; 51(3):152-158. PubMed ID: 27738400
[TBL] [Abstract][Full Text] [Related]
9. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
[TBL] [Abstract][Full Text] [Related]
10. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
11. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
12. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson Syndrome: A Challenging Diagnosis.
Davis WD; Schafer PA
Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
[TBL] [Abstract][Full Text] [Related]
14. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
17. A Review of the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Woolum JA; Bailey AM; Baum RA; Metts EL
Adv Emerg Nurs J; 2019; 41(1):56-64. PubMed ID: 30702535
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
Ghislain PD; Roujeau JC
Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
[TBL] [Abstract][Full Text] [Related]
19. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
[TBL] [Abstract][Full Text] [Related]
20. Toxic epidermal necrolysis: a paradigm of critical illness.
Estrella-Alonso A; Aramburu JA; González-Ruiz MY; Cachafeiro L; Sánchez MS; Lorente JA
Rev Bras Ter Intensiva; 2017; 29(4):499-508. PubMed ID: 29340540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
